Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis

Current Medicinal Chemistry
Laura Vergani

Abstract

Fatty liver, or steatosis, is a condition of excess accumulation of lipids, mainly under form of triglycerides (TG), in the liver, and it is the hallmark of non-alcoholic fatty liver disease (NAFLD). NAFLD is the most common liver disorder world-wide and it has frequently been associated with obesity, hyperlipidemia and insulin resistance. Free fatty acids (FA) are the major mediators of hepatic steatosis; patients with NAFLD have elevated levels of circulating FA that correlate with disease severity. Steatosis is a reversible condition that can be resolved with changed behaviors, or that can progress towards more severe liver damages such as steatohepatitis (NASH), fibrosis and cirrhosis. In NAFLD, FA of exogenous or endogenous origin accumulate in the hepatocytes and trigger liver damages. Excess TG are stored in cytosolic lipid droplets (LDs) that are dynamic organelles acting as hubs for lipid metabolism. In the first part of this review, we briefly reassumed the main classes of FA and their chemical classification as a function of the presence and number of double bonds, their metabolic pathways and effects on human health. Then, we summarized the main genetic and diet-induced animal models of NAFLD, as well as the cellula...Continue Reading

References

Aug 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·R P Mensink, M B Katan
Nov 1, 1994·Proceedings of the Society for Experimental Biology and Medicine·M MorimotoS W French
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·J D HortonH Shimano
Apr 17, 1999·Molecular and Cellular Biology·M ForetzF Foufelle
May 2, 2001·Cell Biochemistry and Biophysics·G P MannaertsM Casteels
Nov 14, 2001·American Journal of Physiology. Gastrointestinal and Liver Physiology·J K Reddy
Nov 21, 2001·Digestive Diseases and Sciences·V NehraK D Lindor
Mar 27, 2002·Molecular Genetics and Metabolism·Amy E BrixPhilip A Wood
Jun 6, 2002·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Yasuyuki OkamotoYoshimasa Haga
May 6, 2003·Nature Genetics·Marianne AbifadelCatherine Boileau
Dec 16, 2003·Journal of Hepatology·Mary E Rinella, Richard M Green
Jun 29, 1951·Science·J MAYERM M DICKIE
Jun 17, 2004·The Journal of Clinical Investigation·Yasuo HorieToru Nakano
Jul 9, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Takayuki MasakiHironobu Yoshimatsu
Aug 6, 2004·The Proceedings of the Nutrition Society·Jürgen PohlWolfgang Stremmel
Aug 28, 2004·Clinics in Liver Disease·Michael W Bradbury, Paul D Berk
Dec 22, 2004·Journal of Gastroenterology and Hepatology·Graeme A Macdonald, Johannes B Prins
Dec 29, 2004·Physiology & Behavior·George A BrayBarry M Popkin
May 3, 2005·The Journal of Clinical Investigation·Kerry L DonnellyElizabeth J Parks
Sep 9, 2005·Current Opinion in Lipidology·Liza Makowski, Gökhan S Hotamisligil
Sep 22, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Qing-Gao DengHidekazu Tsukamoto
Sep 22, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zhiping LiAnna Mae Diehl
Jan 27, 2006·International Journal of Experimental Pathology·Quentin M Anstee, Robert D Goldin
Feb 16, 2006·Molecular and Cellular Biochemistry·Robert EhehaltWolfgang Stremmel
Mar 1, 2006·The Journal of Biological Chemistry·Harmeet MalhiGregory J Gores
Dec 26, 2006·Chemico-biological Interactions·María José Gómez-LechónJosé-Enrique O'Connor
Jun 15, 2007·Laboratory Investigation; a Journal of Technical Methods and Pathology·Andrea De GottardiAntoine Hadengue
Sep 18, 2007·Journal of Hepatology·Ashraf Mohammad El-BadryPierre-Alain Clavien
Oct 12, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Naoto MatsuzawaShuichi Kaneko
Jan 17, 2008·Progress in Lipid Research·Gerd Schmitz, Josef Ecker
Feb 7, 2008·Mediators of Inflammation·Nektaria TsantilaConstantinos A Demopoulos
Apr 1, 2008·Experimental Biology and Medicine·Elena GrasselliLaura Vergani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.